Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
7-amino-2-tert-butyl-4-(4-pyrimidin-2-ylpiperazin-1-yl)pyrido[2,3-d]pyrimidine-6-carboxamide is a synthetic organic compound with the molecular formula C20H25N9O. While its chemical structure is precisely defined and recognized in chemical databases like PubChem (CID 25023707), specific information regarding its canonical name, code names, brand names, developers, manufacturers, mechanism of action, or development status as a drug is not readily available in the public domain through the conducted searches. Compounds with similar pyrido[2,3-d]pyrimidine or pyrimidine scaffolds are often investigated for their kinase inhibitory activities and potential anticancer properties, targeting various kinases such as BRD4/PLK1, FLT3/CDK, Akt, EGFR, PIM-1, and CDK4/ARK5. However, no direct link between this specific compound and any reported biological activity or therapeutic application could be established from the available information.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on 7-amino-2-tert-butyl-4-(4-pyrimidin-2-ylpiperazin-1-yl)pyrido[2,3-d]pyrimidine-6-carboxamide.